{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:04:55Z","timestamp":1791515095237,"version":"4.3.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","award":["RD003259"],"award-info":[{"award-number":["RD003259"]}],"id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The global burden of sexually transmitted infections (STIs) is high and there have been reports of increasing chlamydial and gonorrheal infections. High-volume screening programs for <jats:italic>Chlamydia trachomatis<\/jats:italic> (CT) and <jats:italic>Neisseria gonorrhoeae<\/jats:italic> (NG) are an important component of STI control. This study evaluated the high-volume workflow and performance of the <jats:bold>cobas\u00ae<\/jats:bold> CT\/NG assay for use on the automated Roche <jats:bold>cobas\u00ae<\/jats:bold> 6800 system, with the <jats:bold>cobas p<\/jats:bold> 480 instrument for pre-analytics, compared with the Aptima Combo 2 assay on the Hologic Panther system.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>High-volume workflow and performance were evaluated using paired female urine specimens. Workflow analysis (<jats:italic>n<\/jats:italic>\u2009=\u2009376) included hands-on time (HoT), number of manual interventions, and time to first and last results. For performance assessment, paired results from the <jats:bold>cobas<\/jats:bold> CT\/NG and Aptima Combo 2 assays, for both CT and NG, were compared and two-sided 95% confidence intervals calculated to provide estimates of positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between the tests. McNemar\u2019s test was used for significance testing.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Pre-analytical preparations and system start-up on the <jats:bold>cobas<\/jats:bold> 6800 system required 00:27:38 (hr:min:sec) HoT whilst the Panther system required 00:30:43. The <jats:bold>cobas<\/jats:bold> 6800 system required eight interactions and 00:43:59 HoT to process 376 samples. The Panther system required six interactions and 00:39:10 HoT. Time to first results was 02:53:00 on the <jats:bold>cobas<\/jats:bold> c6800 system for 96 samples and 03:28:29 on the Panther system for five samples. The <jats:bold>cobas<\/jats:bold> 6800 system delivered all 376 results 3\u2009h faster than the Panther system (07:45:26 and 10:47:30, respectively). The performance correlation between both assays was high (PPA, NPA and OPA &gt;\u200999% for both CT and NG). McNemar\u2019s test revealed no statistically significant difference between the assays.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>For high-volume automated CT\/NG testing, both the <jats:bold>cobas<\/jats:bold> 6800 system and Panther system provided accurate results. Although less manual intervention steps were needed for the Panther system, improved turnaround time was obtained with the <jats:bold>cobas<\/jats:bold> 6800 system with less risk for contamination. The additional testing capacity on the <jats:bold>cobas<\/jats:bold> 6800 system would allow a growing service to deliver more results in a single shift.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4442-0","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:51:48Z","timestamp":1568184708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms"],"prefix":"10.1186","volume":"19","author":[{"given":"Andr\u00e9","family":"Frontzek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Aretzweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Marlowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"issue":"12","key":"4442_CR1","doi-asserted-by":"publisher","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.","journal-title":"PLoS One"},{"key":"4442_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Sexually Transmitted Disease Surveillance 2017. 2018. \n                    https:\/\/www.cdc.gov\/std\/stats17\/2017-STDSurveillance-Report_CDC-clearance-9.10.18.pdf\n                    \n                  ."},{"issue":"5","key":"4442_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","volume":"67","author":"MW Traeger","year":"2018","unstructured":"Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676\u201386.","journal-title":"Clin Infect Dis"},{"key":"4442_CR4","doi-asserted-by":"crossref","unstructured":"Enomoto C, Noor S, Widner N. Is social media to blame for the sharp rise in STDs? Soc Sci. 2017;6(3):78. \n                    https:\/\/doi.org\/10.3390\/socsci6030078\n                    \n                  .","DOI":"10.3390\/socsci6030078"},{"issue":"5","key":"4442_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0956462415618837","volume":"27","author":"E Lanjouw","year":"2015","unstructured":"Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M, et al. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333\u201348.","journal-title":"International Journal of STD & AIDS"},{"issue":"2","key":"4442_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M, European STI. Guidelines editorial board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85\u201392.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"4442_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","volume":"36","author":"TA Fairley","year":"2003","unstructured":"Fairley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med. 2003;36(4):502\u20139.","journal-title":"Prev Med"},{"key":"4442_CR8","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for the laboratory-based detection of chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep. 2014;63:RR\u201302):1\u201319."},{"key":"4442_CR9","unstructured":"Roche Molecular Systems. cobas\u00ae CT\/NG assay [Package insert]. 2018. \n                     https:\/\/pim-eservices.roche.com\/eLD_SF\/gb\/en\/Documents\/GetDocument?documentId=b2f93133-7cc8-e611-6498-00215a9b3428\n                    \n                  ."},{"key":"4442_CR10","unstructured":"Hologic. Aptima Combo 2\u00ae Assay [Package insert]. 2017."},{"key":"4442_CR11","unstructured":"College of American Pathologists. CAP TODAY. 2018. p. 58\u201362. \n                    http:\/\/digital.olivesoftware.com\/Olive\/ODN\/CAPToday\/default.aspx\n                    \n                  ."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4442-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T16:49:17Z","timestamp":1599756557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4442-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4442-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the \u00c4rztekammer Nordrhein, North Rhine Westphalia, Germany waived the need for ethics approval and the need to obtain consent for the collection, analysis, and publication of the retrospectively obtained and anonymized data for this non-interventional study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EMM and DD are employees of Roche Molecular Diagnostics. AF has received honoraria as a consultant and speaker for Roche Molecular Systems, Inc. and Roche Diagnostics Deutschland GmbH. The other authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"797"}}